Consensus Development Program
This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (October 2024) |
The Consensus Development Program is an initiative focused on gathering expert opinions to establish standards and guidelines in various fields, especially in health and medicine. Developed as a collaborative effort by organizations such as the National Institutes of Health (NIH), the program assembles panels of specialists who assess available evidence on critical topics and form recommendations to guide clinical practice and policy. This method helps ensure that healthcare decisions are informed by the latest scientific research and expert consensus.[1]
Objectives
[edit]The primary objective of the Consensus Development Program is to provide authoritative guidance on healthcare practices by evaluating scientific data and expert knowledge. The program covers a broad range of topics, including cancer treatments, diagnostic methods, and preventive strategies. By facilitating a structured discussion among experts, the program aims to bridge gaps in knowledge, encourage research, and ultimately improve patient outcomes.[2]
Process
[edit]The program typically follows a systematic process, beginning with the selection of a topic that requires consensus. This is followed by a thorough review of existing literature and data, with the assistance of resources such as PubMed and the National Library of Medicine (NLM). Expert panels then deliberate in workshops and public sessions, where they discuss findings and draft recommendations. The final step involves disseminating the panel's conclusions to stakeholders, including healthcare providers, policymakers, and the public.[3]
Impact on Cancer Treatment
[edit]The Consensus Development Program has had a significant influence on cancer care, offering evidence-based recommendations that shape screening guidelines, treatment protocols, and patient care strategies. The program addresses issues such as the benefits and risks of specific treatments, the development of new diagnostic tools, and the ethical considerations in cancer care. The comprehensive approach ensures that recommendations are based on a balanced view of risks and benefits.[4]
References
[edit]- ^ "Consensus Development Program". National Cancer Institute. Retrieved 2024-10-03.
- ^ Paul, H. (2015). "Evaluating Consensus Development Programs in Healthcare". Journal of Health Services Research. 34 (7): 965–973. doi:10.1016/j.jhsr.2015.06.015 (inactive 1 November 2024).
{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)[dead link] - ^ Smith, J. (2018). "Systematic Reviews in Consensus Development: Applications and Benefits". Healthcare Policy Journal. 23 (5): 389–401. doi:10.1016/j.hp.2018.04.004 (inactive 1 November 2024).
{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)[dead link] - ^ Jones, M. (2020). "Consensus Development in Cancer Treatment: A Model for Evidence-Based Practice". Oncology Reviews. 42 (2): 112–120. doi:10.1097/OR.0000000000000012 (inactive 1 November 2024).
{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)[dead link]